Heterocyclic-substituted quinolone inotropic agents
CA 1253497 A · Owner: Pfizer Corporation · Inventors: Roberts, David A.; Campbell, Simon F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
9387-64, Abstract of the Disclosure, A quinolone inotropic agent of the formula:- --- (I), or a pharmaceutically acceptable salt thereof wherein "Het" is an optionally, substituted 5- or 6-membered monocyclic aromatic heterocyclic group attached by a carbon atom to the 5-, 6-, 7- or 8- position of said quinolone; R which is, attached to the 5-, 6-, 7- or 8- position is hydrogen, C1-C4 alkyl; C1-C4, alkoxy C1-C4 alkylthio, C1-C4 alkylsulphinyl, C1-C4 alkylsulphonyl halo, CF3, hydroxy, hydroxymethyl, or cyano; R1 is hydrogen cyano, (C1-C4 alkoxy)-, carbonyl, C1-C4 alkyl nitro, halo, -NR3R4 or -CONR3R4 where R3 and R4 are each independently H or C1-C4 alkyl or together with the nitrogen atom …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted May 2, 1989. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended May 2, 2006.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.